NOTE 9 – STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)												12 Months Ended
	Aug. 31, 2024	Aug. 19, 2024	Jul. 20, 2024	Jun. 13, 2024	Apr. 22, 2024	Feb. 05, 2024	Oct. 05, 2023	Sep. 08, 2023	Jun. 12, 2023	Sep. 06, 2022	Aug. 02, 2022	Aug. 31, 2024	Aug. 31, 2023	Jun. 21, 2023	Oct. 11, 2022	Oct. 10, 2022	Aug. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.001											$ 0.001	$ 0.001
Stockholders' Equity, Reverse Stock Split					On April 22, 2024, the Board of Directors approved a reverse split of the Corporation’s issued and outstanding common stock, which has a par value $0.001 per share. The reverse split ratio has been determined at 1 for 2,000 shares. The effectiveness of this reverse split is contingent upon receiving approval from the Financial Industry Regulatory Authorization (FINRA				On June 12, 2023, the Board of Directors approved a reverse split for the Company’s issued and outstanding common stock, at a ratio of 1 share for every 10,000 shares, contingent upon receiving a market effectiveness date from FINRA
[custom:StockholdersEquityReverseStockSplitCancellation]		On August 19, 2024, the Board of Directors decided to cancel the company's upcoming 1-for 2,000 reverse split. The Board of Directors decided it would not be in the best interest of the stockholders or the Company to execute a reverse split at this time. The Company plans to inform FINRA that it will not be moving forward with the reverse split and will withdraw its application						On September 8, 2023, however, the Board of Directors decided to cancel the company's upcoming 10,000 to 1 reverse split. The Board of Directors decided it would not be in the best interest of the shareholders or the Company to execute a reverse split at this time. The Company informed FINRA that it will not be moving forward with the reverse split withdrew its application
Payments for Repurchase of Common Stock			$ 50,699
Accelerated Share Repurchases, Final Price Paid Per Share												$ 0.001
Common Stock, Shares Authorized	10,000,000,000											10,000,000,000	10,000,000,000		10,000,000,000	1,000,000,000
Proceeds from Issuance of Common Stock													$ 146,475
Common Stock, Shares, Issued	2,281,266,321											2,281,266,321	1,285,283,385
Common Stock, Shares, Outstanding	2,281,266,321											2,281,266,321	1,285,283,385
[custom:SeriesCPreferredSharesIssuedAmount]													$ 69,000
Dividend, Share-Based Payment Arrangement												$ 0	$ 31,387
Original Shares Issued [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of Warrant or Right, Outstanding	1,993,304,434											1,993,304,434	50,000,000				50,000,000
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life												4 years 8 months 26 days
Preferred Class C [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of Stock, Shares Converted												174,421	250,268
Series C Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
[custom:SeriesCPreferredSharesIssuedShares]										90,275
[custom:SeriesCPreferredSharesIssuedAmount]										$ 78,500
Proceeds from Issuance of Convertible Preferred Stock										$ 69,000
C E O [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accrued Salaries, Current							$ 45,000
C E O [Member] | Restricted Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture							225,000,000
Common Stock, Par or Stated Value Per Share							$ 0.001
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock Issued During Period, Shares, Conversion of Units												1,056,681,936	700,770,802
[custom:StockCancelledDuringPeriodSharesCommonShares]						235,000,000
[custom:SeriesCPreferredSharesIssuedShares]
[custom:SeriesCPreferredSharesIssuedAmount]
July 2024 Share Repurchase [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock Repurchased During Period, Shares			50,699,000
Payments for Repurchase of Common Stock	$ 38,485
Alumni Capital Agreement Two [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Long-Term Purchase Commitment, Amount				$ 5,000,000
Long-Term Purchase Commitment, Specified Form of Payment				Pursuant to the Purchase Agreement, the Investment Amount means seventy percent (70%) of the lowest daily Volume Weighted Average Price (“VWAP”) of the Common Stock five business days prior to the Closing of a Purchase Notice. No Purchase Notice will be made without an effective registration statement and no Purchase Notice will be in an amount greater than (i) $250,000 or (ii) three hundred percent (300%) of the Average Daily Trading Volume during the five business days prior to a Purchase Notice
Debt Instrument, Convertible, Associated Derivative Transactions, Description				he number of our common stock shares to be sold to Alumni Capital will not exceed the number of shares that, when aggregated together with all other shares of our common stock which the investor is deemed to beneficially own, would result in the investor owning more than 4.99% of our outstanding common stock. The percentage may be increased to no more than 9.99% upon notice under the Purchase Agreement
Alumni Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt Instrument, Convertible, Associated Derivative Transactions, Description											The purchase price is number of common stocks in a Purchase Notice issued by the Company multiplied by 75% of the lowest traded price of the Common Stock five Business Days prior to the Closing, which is no later than five business days after the Purchase Notice Date.
Derivative Liability, Securities Sold under Agreements to Repurchase, Securities Loaned											$ 1,000,000.0
Common Stock, Shares Subscribed but Unissued													200,000,000
Alumni Capital Total Proceeds [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from Issuance of Common Stock													$ 146,475
Alumni Capital Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued				1,943,304,434
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.00129
Warrants and Rights Outstanding, Term				5 years
Debt Instrument, Call Feature				The number of shares under the Common Stock Purchase Warrant is subject to adjustment based on the following formula: (i) fifty percent (50%) of the Commitment Amount, less the exercise value of all partial exercises prior to the Exercise Date, divided by (ii) the Exercise Price on the Exercise Date. The exercise price per was calculated by dividing $3,000,000 by the total number of issued and outstanding shares of common stock as of June 13, 2024
Derivative Asset, Subject to Master Netting Arrangement, before Offset				$ 970,945
Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]				The fair value has been estimated using the Black-Scholes pricing model with the following assumptions: market value of underlying common shares of $0.0005; risk free rate of 4.24%; expected term of 5 years; exercise price of $0.0013; volatility of 310.94%; and expected future dividends of $0
Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock Issued During Period, Shares, Conversion of Units												(174,421)	(250,268)
[custom:SeriesCPreferredSharesIssuedShares]													90,275
[custom:SeriesCPreferredSharesIssuedAmount]													$ 90
Preferred Stock [Member] | Preferred Class C [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of Stock, Shares Converted												174,421
Preferred Class C [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
[custom:StockWaivedDuringPeriodByAccreditedInvestor-0]														1,436